Bellevue Group AG - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 168 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,446,000
+2.0%
300,000
+200.0%
0.02%
-70.5%
Q1 2019$1,417,000
+10.3%
100,000
+5.3%
0.08%
-7.1%
Q4 2018$1,285,000
-39.0%
95,0000.0%0.08%
-37.3%
Q3 2018$2,108,000
+71.2%
95,000
+26.7%
0.13%
+27.6%
Q2 2018$1,231,00075,0000.10%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders